Recent Articles
Don’t Sweat a BUD Monopoly
Jan. 14, 2013, 1:08 pm EDT – Rumor has it the Department of Justice will nix a Grupo Modelo merger -- but such a move ignores the very nature of competition in the beer space. More
Biotech Movers: Dendreon Pops, ArQule Drops
Jan. 14, 2013, 9:00 am EDT – An analyst upgrade on DNDN lifted the shares 21% last Friday, but mid-stage trial failure of a colorectal drug sank ARQL 11% the same day. More
Want a Bull Market in 2013? Root for … the Buckeyes!
Jan. 7, 2013, 1:08 pm EDT – Yeah, it's a long shot, but if Ohio State walked away as the AP's national champion in college football, it would be huge for the market ... if the 'indicator' posited by Bespoke holds true, that is. More
ETFs in 2013: What’s Left?
Dec. 20, 2012, 7:45 am EDT – ETFs will remain popular investment vehicles, but can we keep slicing the pie in new and different ways? (Hint: No.) More
Biotech Movers: Ariad Sinks, YM Soars
Dec. 17, 2012, 9:10 am EDT – They were among the sector's big newsmakers last week, with Acadia, Oncolytics and Acura Pharmaceuticals. More
Top 10 Dow Dividend Stocks for December
Dec. 14, 2012, 6:30 am EDT – Income investors could do a lot worse than buying into these venerable blue chips, but some only have great yields thanks to a not-so-hot year. More
Fidelity Cutting Fees on 8 Index Funds
Dec. 13, 2012, 10:26 am EDT – Fidelity Investments is lowering costs on eight of its Spartan index mutual funds, as well as lowering investment minimums across 22 funds. More
Biotech Movers: A Tough Week All Around
Dec. 10, 2012, 9:15 am EDT – Amarin Corp. slides on dashed buyout hopes, while Sarepta, Galena and others also faced serious setbacks. More
Macy’s Holiday Plan: A 48-Hour Brain Fart
Dec. 7, 2012, 6:45 am EDT – No one's complaining that Macy's is taking a page out of Walmart and Target's book with extended holiday hours; the move just makes little sense. More
Forget Earnings — For DFS, It’s All About the Fiscal Cliff
Dec. 7, 2012, 6:15 am EDT – All things being equal, quarterly numbers don't tend to move Discover much. Here's what DFS investors should consider instead. More
